NeuroPace (NPCE) FCF Margin (2020 - 2026)
NeuroPace's quarterly FCF Margin came in at 27.25% in Q1 2026, up 621.0% year-on-year from 3.78% in Q1 2025, and down 1566.76% quarter-over-quarter from 1.86% in Q4 2025.
NeuroPace has reported FCF Margin for 7 years, with the latest figure at 27.25% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 621.0% year-over-year to 27.25%; the trailing twelve-month figure through Mar 2026 stood at 9.54% (up 1166.0% YoY), and the FY2025 full-year result was 11.02%, up 1140.0% from the prior year.
- FCF Margin for Q1 2026 stood at 27.25%, down from 1.86% in the prior quarter.
- The five-year high for FCF Margin was 1.86% in Q4 2025, with the low at 104.49% in Q2 2022.
- Average FCF Margin over 5 years is 36.68%, with a median of 26.66% recorded in 2023.
- Year-over-year, FCF Margin sank 5687 bps in 2022 and surged 7783 bps in 2023.
- Tracing NPCE's FCF Margin over 5 years: stood at 58.82% in 2022, then jumped by 69 bps to 18.15% in 2023, then slipped by 21 bps to 21.98% in 2024, then jumped by 108 bps to 1.86% in 2025, then plunged by 1567 bps to 27.25% in 2026.
- The last three FCF Margin figures came in at 27.25% (Q1 2026), 1.86% (Q4 2025), and 6.9% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -27.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.25% |
| Dec 31, 2025 | 1.86% |
| Sep 30, 2025 | -6.90% |
| Jun 30, 2025 | -8.88% |
| Mar 31, 2025 | -33.46% |
| Dec 31, 2024 | -21.98% |
| Sep 30, 2024 | -8.41% |
| Jun 30, 2024 | -19.97% |
| Mar 31, 2024 | -41.84% |
| Dec 31, 2023 | -18.15% |
| Sep 30, 2023 | -13.81% |
| Jun 30, 2023 | -26.66% |
| Mar 31, 2023 | -67.92% |
| Dec 31, 2022 | -58.82% |
| Sep 30, 2022 | -66.50% |
| Jun 30, 2022 | -104.49% |
| Mar 31, 2022 | -100.44% |
| Dec 31, 2021 | -75.97% |
| Sep 30, 2021 | -45.27% |
| Jun 30, 2021 | -47.62% |
| Mar 31, 2021 | -52.92% |
| Dec 31, 2020 | -60.10% |
| Sep 30, 2020 | -42.47% |
| Jun 30, 2020 | -42.67% |
| Mar 31, 2020 | -65.32% |